SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

Authors:
Bousquet E; Beydoun T; Rothschild PR; Bergin C; Zhao M and 7 more

Journal:
Retina

Publication Year: 2015

DOI:
10.1097/IAE.0000000000000614

PMCID:
PMC4697359

PMID:
26017871

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Retina

Abbreviation: Retina

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
CORRELATIONS BETWEEN SUSPENDED HYPERREFLECTIVE MATERIAL WITH THE MACULAR MICROSTRUCTURE AND SPONTAN…
Yang Q; Huang X; Peng R and 4 more (2024) - Transparency Score: 3/6
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Non…
Boyer D; Hu A; Warrow D and 14 more (2024) - Transparency Score: 3/6
RETINAL OPTICAL COHERENCE TOMOGRAPHY IMAGING BIOMARKERS: A Review of the Literature.
Pandya BU; Grinton M; Mandelcorn ED and 1 more (2024) - Transparency Score: 3/6
ACCURACY OF NEW INTRAOCULAR LENS CALCULATION FORMULAE IN EYES UNDERGOING SILICONE OIL REMOVAL/PARS …
Chen X; Zhao H; Xu Y and 9 more (2023) - Transparency Score: 3/6
A New Technique of Pars Plana Vitrectomy With Microinterventional Nucleus Disassembly to Reduce the…
Jimenez JA; Yanoga F; Ohr MP. (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"F. Behar-Cohen and N. Farman are inventors on a patent protecting the use of MR antagonists for retinal edema. The patent rights belong to Inserm. None of the remaining authors have any conflicting interests to disclose."

Evidence found in paper:

"Inserm provided financial support for the statistical analysis and was promoter of the study."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025